These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26808227)

  • 21. Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations.
    Wingler LM; Elgeti M; Hilger D; Latorraca NR; Lerch MT; Staus DP; Dror RO; Kobilka BK; Hubbell WL; Lefkowitz RJ
    Cell; 2019 Jan; 176(3):468-478.e11. PubMed ID: 30639099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct in vivo target occupancy by bivalent- and induced-fit-like binding drugs.
    Vauquelin G
    Br J Pharmacol; 2017 Dec; 174(23):4233-4246. PubMed ID: 28838028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
    Patny A; Desai PV; Avery MA
    Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the role of the membrane bilayer in the recognition of candesartan by its GPCR AT1 receptor.
    Kiriakidi S; Chatzigiannis C; Papaemmanouil C; Tzakos AG; Mavromoustakos T
    Biochim Biophys Acta Biomembr; 2020 Mar; 1862(3):183142. PubMed ID: 31830465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor.
    Meyer M; Foulquier S; Dupuis F; Flament S; Grimaud L; Henrion D; Lartaud I; Monard G; Grillier-Vuissoz I; Boisbrun M
    Eur J Med Chem; 2018 Oct; 158():334-352. PubMed ID: 30223121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs with Angiotensin Type 1 Receptor.
    Singh KD; Unal H; Desnoyer R; Karnik SS
    J Chem Inf Model; 2018 Jan; 58(1):182-193. PubMed ID: 29195045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ by core hopping of telmisartan.
    Zhang J; Liu X; Wang SQ; Liu GY; Xu WR; Cheng XC; Wang RL
    J Biomol Struct Dyn; 2017 Sep; 35(12):2665-2680. PubMed ID: 27602589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AT1 receptor antagonists.
    Verheijen I; Vanderheyden PM; De Backer JP; Vauquelin G
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):69-77. PubMed ID: 15320808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic characterization of AT1 receptor antagonists with label-free dynamic mass redistribution assays.
    Qu L; Wang J; Hou T; Zhou H; Wang Z; Zhang X; Liang X
    J Pharmacol Toxicol Methods; 2020; 102():106682. PubMed ID: 32087363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homology modeling, binding site identification and docking study of human angiotensin II type I (Ang II-AT1) receptor.
    Vyas VK; Ghate M; Patel K; Qureshi G; Shah S
    Biomed Pharmacother; 2015 Aug; 74():42-8. PubMed ID: 26349961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
    Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin Mediated Oxidative Stress and Neuroprotective Potential of Antioxidants and AT1 Receptor Blockers.
    Prusty SK; Sahu PK; Subudhi BB
    Mini Rev Med Chem; 2017; 17(6):518-528. PubMed ID: 27781960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies.
    Ojima M; Igata H; Tanaka M; Sakamoto H; Kuroita T; Kohara Y; Kubo K; Fuse H; Imura Y; Kusumoto K; Nagaya H
    J Pharmacol Exp Ther; 2011 Mar; 336(3):801-8. PubMed ID: 21123673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor.
    Aplin M; Christensen GL; Hansen JL
    Trends Cardiovasc Med; 2008 Nov; 18(8):305-12. PubMed ID: 19345318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased vascular angiotensin II binding capacity and ET-1 release in young cardiomyopathic hamsters.
    Crespo MJ; Altieri PI; Escobales N
    Vascul Pharmacol; 2006 Apr; 44(4):247-52. PubMed ID: 16503205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Other Angiotensin II Receptor: AT
    Juillerat-Jeanneret L
    J Med Chem; 2020 Mar; 63(5):1978-1995. PubMed ID: 32030982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors.
    Mogi M; Iwai M; Horiuchi M
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2532-9. PubMed ID: 17717300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
    Kakuta H; Sudoh K; Sasamata M; Yamagishi S
    Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.